You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME/CE

What's Next in Patients With Type 2 Diabetes Not Achieving Glycemic Targets?

  • Authors: Luigi F. Meneghini, MD; Anne L. Peters, MD, CDE
  • CME/CE Released: 7/28/2011
  • THIS ACTIVITY HAS EXPIRED
  • Valid for credit through: 7/28/2012
Start Activity


Target Audience and Goal Statement

This activity is intended for primary care providers, nurses, endocrinologists, diabetologists, certified diabetes educators, pharmacists, and other healthcare professionals who treat patients with type 2 diabetes (T2D).

The goal of this activity is to review strategies for initiation and intensification of insulin therapy and to maximize treatment adherence in patients with T2D in order to optimize glycemic control.

Upon completion of this activity, participants will be able to:

  1. Outline circumstances in which insulin therapy should be initiated and strategies for intensifying and optimizing therapy
  2. Identify factors that may lead to poor adherence among patients receiving insulin therapy
  3. Apply strategies to improve adherence to insulin therapy, particularly at mealtimes


Disclosures

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Authors

  • Luigi F. Meneghini, MD

    Associate Professor of Clinical Medicine; Director, University of Miami Miller School of Medicine; Director, Kosow Diabetes Treatment Center, Diabetes Research Institute, Miami, Florida

    Disclosures

    Disclosure: Luigi F. Meneghini, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Novo Nordisk
    Received grants for clinical research from: Novo Nordisk; Mankind Pharma

    Dr. Meneghini does intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the US Food and Drug Administration (FDA) for use in the United States.

    Dr. Meneghini does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

  • Anne L. Peters, MD, CDE

    Professor of Clinical Medicine, Keck School of Medicine, University of Southern California; Director, USC Clinical Diabetes Program, Los Angeles, California

    Disclosures

    Disclosure: Anne L. Peters, MD, CDE, has disclosed the following relevant financial relationships:
    Served as a speaker or a member of a speakers bureau for: Amylin Pharmaceuticals, Inc.; Eli Lilly & Company; Takeda Pharmaceuticals North America, Inc.; Novo Nordisk
    Served as an advisor or consultant for: Amylin Pharmaceuticals, Inc.; Eli Lilly & Company; Novo Nordisk

    Dr. Peters does intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

    Dr. Peters does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Editors

  • Anne Le, PhD

    Scientific Director, Medscape, LLC

    Disclosures

    Disclosure: Anne Le, PhD, has disclosed no relevant financial relationships.

  • Simone Stromer, MD

    Scientific Director, Medscape, LLC

    Disclosures

    Disclosure: Simone Stromer, MD, has disclosed no relevant financial relationships.

CME Reviewer

  • Nafeez Zawahir, MD

    CME Clinical Director, Medscape, LLC

    Disclosures

    Disclosure: Nafeez Zawahir, MD, has disclosed no relevant financial relationships.

Nurse Planner

  • Laurie E. Scudder, DNP, NP

    Nurse Planner, Continuing Professional Education Department, Medscape, LLC; Clinical Assistant Professor, School of Nursing and Allied Health, George Washington University, Washington, DC

    Disclosures

    Disclosure: Laurie E. Scudder, DNP, NP, has disclosed no relevant financial relationships.


Accreditation Statements

    For Physicians

  • Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Medscape, LLC staff have disclosed that they have no relevant financial relationships.

    Contact This Provider

    For Nurses

  • Medscape, LLC is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

    Awarded 0.50 contact hour(s) of continuing nursing education for RNs and APNs; none of these credits is in the area of pharmacology.

    Accreditation of this program does not imply endorsement by either Medscape, LLC or ANCC.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. Medscape Education encourages you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.

*The credit that you receive is based on your user profile.

CME/CE

What's Next in Patients With Type 2 Diabetes Not Achieving Glycemic Targets?

Authors: Luigi F. Meneghini, MD; Anne L. Peters, MD, CDEFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED

CME/CE Released: 7/28/2011

Valid for credit through: 7/28/2012

processing....

 

This feature requires the newest version of Flash. You can download it here.
  • Print